< Back to previous page
Researcher
Lindsay Poppe
- Disciplines:Neurosciences, Biological and physiological psychology, Cognitive science and intelligent systems, Developmental psychology and ageing
Affiliations
- Laboratory for Neurobiology (VIB-KU Leuven) (Lab)
Member
From1 Sep 2012 → 10 Aug 2020
Publications
1 - 8 of 8
- Exploration of the role of EphA4 in neurodegenerative diseases.(2020)
Authors: Lindsay Poppe, Wim Robberecht, Philip Van Damme
- Environmental enrichment during the chronic phase after experimental stroke promotes functional recovery without synergistic effects of EphA4 targeted therapy(2020)
Authors: Lindsay Poppe, Wim Robberecht, Robin Lemmens
Pages: 605 - 617 - EphA4 loss improves social memory performance and alters dendritic spine morphology without changes in amyloid pathology in a mouse model of Alzheimer's disease(2019)
Authors: Lindsay Poppe, Philip Van Damme, Ludo Van Den Bosch, Rudi D'Hooge, Bart De Strooper, Wim Robberecht, Robin Lemmens
- Lowering EphA4 Does Not Ameliorate Disease in a Mouse Model for Severe Spinal Muscular Atrophy(2019)
Authors: Lindsay Poppe, Philip Van Damme, Ludo Van Den Bosch, Wim Robberecht, Robin Lemmens
- Reducing EphA4 before disease onset does not affect survival in a mouse model of Amyotrophic Lateral Sclerosis(2019)
Authors: Lindsay Poppe, Ludo Van Den Bosch, Philip Van Damme, Wim Robberecht, Robin Lemmens
- Reduction of ephrin-A5 aggravates disease progression in amyotrophic lateral sclerosis(2019)
Authors: Lindsay Poppe, Antina de Boer, Ludo Van Den Bosch, Philip Van Damme, Wim Robberecht, Robin Lemmens
- Heterozygous Deletion of EphrinA5 Does Not Improve Functional Recovery After Experimental Stroke(2019)
Authors: Antina de Boer, Lindsay Poppe, Wim Robberecht, Robin Lemmens
Pages: E101 - E101 - Translating biological findings into new treatment strategies for amyotrophic lateral sclerosis (ALS)(2014)
Authors: Lindsay Poppe, Wim Robberecht, Ludo Van Den Bosch
Pages: 138 - 151